telehealth.helpFind my match

Home Weight loss (GLP-1) By state New York

NY Medicaid's BMI 40 Rule for GLP-1s: 8 programs ship to NY

New York gives three different answers on GLP-1 coverage, depending on who pays for your plan. NYSHIP's Empire Plan lists Wegovy and Zepbound with prior authorization. NYRx, the Medicaid drug program, excludes weight loss by regulation and opens only two narrow medical exceptions at a BMI of 40. City workers and members of certain Excellus plans lost coverage in 2025 and 2026. This page sorts out which group you are in. The lowest price we found from a program that ships to New York: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.

  • Updated
  • Prices read Nov 12, 2026

New York at a glance

New York Medicaid
Does not cover for weight loss
State employee plan
Covers GLP-1s for weight loss
Adults with obesity
28.5% (2025)
Programs we compare that ship to NY
8 of 22

Online GLP-1 programs for New York, cheapest first

Programs that ship to New York. Prescribed online by a licensed clinician; medication and delivery included.

How we pick and check programs

Our pick for November 2026

Daily oral plan
Intro offer: from $7 a day

A daily oral GLP-1 plan. No needles, no injections

GLP-1 protocol from$199/moon the 3-month plan with the $100 welcome credit ($299 without), shipped monthly; the home page names no form for this plan (the oral offer is from $7 a day)
Visit HumeCare Read our HumeCare review

Compounded semaglutide in New York: lowest monthly price

#ProgramLowest priceMonth to monthLink
1LttlCheapest$89/mo 12-month plan$99 / 4 wksVisitLttl
2BetterMe Rx$99/mo 12-month plan$199/moVisitBetterMe Rx
3Refills$99/mo $99 / 4 wksVisitRefills
4Direct Meds$297/mo $297/moVisitDirect Meds
5GalaFrom $69/mo starting price, plan length not statedNot statedVisitGala
6TrimRxFrom $349/mo starting price, plan length not statedNot statedVisitTrimRx

Compounded tirzepatide in New York: lowest monthly price

#ProgramLowest priceMonth to monthLink
1MaximusCheapest$99.99/mo 12-month planNot offeredVisitMaximus
2Lttl$139/mo 12-month plan$149 / 4 wksVisitLttl
3BetterMe Rx$159/mo 12-month plan$249/moVisitBetterMe Rx
4Refills$159/mo $159 / 4 wksVisitRefills
5Direct Meds$399/mo $399/moVisitDirect Meds
6GalaFrom $99/mo starting price, plan length not statedNot statedVisitGala
7TrimRxFrom $279/mo starting price, plan length not statedNot statedVisitTrimRx
  1. Low month-to-month#1
    Up to $140 off your first month

    Compounded semaglutide for $99, month to month

    Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month plan
    Visit Lttl Read our Lttl review
  2. Pills or shots#2
    Semaglutide from $99/mo

    Choose weekly shots or daily tablets; shots from $99/mo on the 12-month plan

    Semaglutide shots from$99/moon the 12-month plan; $199 month to month
    Visit BetterMe Rx Read our BetterMe Rx review
  3. No contract#3
    Fall sale: 40% off

    Compounded semaglutide as low as $99 a month

    Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale
    4.2 on Trustpilot1,779 reviews ·
    Visit Refills Read our Refills review
  4. Low-cost tirzepatide#4
    Same price at every dose

    Compounded tirzepatide from $99.99 a month

    Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months
    4.4 on Trustpilot1,106 reviews ·
    Visit Maximus Read our Maximus review
  5. Delivery in 1-2 days#5
    Fall sale: $150 off

    Same price at every dose, at your door in 1-2 days

    Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"
    4.5 on Trustpilot17,724 reviews ·
    Visit Direct Meds Read our Direct Meds review

3 more programs are in the price tables above.

Empire Plan yes, Excellus maybe: the commercial side

NYSHIP's Empire Plan lists Wegovy and Zepbound on its 2026 drug list with prior authorization, which puts state workers and many local public employees among the better-covered New Yorkers. Approval is still a paperwork step: your clinician submits your BMI and health history, and the plan decides. Local employers that buy into NYSHIP can choose different options, so read your own drug list and copay before you fill.

Upstate, Excellus BlueCross BlueShield took Wegovy, Zepbound and Saxenda for weight loss off the drug list of certain plans on January 1, 2026. A prescriber can still ask for an exception by showing you meet the plan's criteria, and GLP-1s prescribed for diabetes stay covered. If your plan says no, online programs that say they serve New York serve the five boroughs, Long Island and upstate, each with its own monthly price.

  • The NYSHIP Empire Plan 2026 drug list includes Wegovy and Zepbound with prior authorization. (cs.ny.gov)
  • Excellus BlueCross BlueShield removed Wegovy, Zepbound and Saxenda for weight loss from certain plans effective January 1, 2026; exceptions are possible. (excellusbcbs.com)
  • Since April 1, 2023, members of mainstream Medicaid managed care plans, HARPs and HIV-SNPs get pharmacy benefits through NYRx; the Essential Plan and Child Health Plus are excluded from the transition. (health.ny.gov)
  • An NYRx notice (revised July 16, 2026) cites 18 NYCRR 505.3(g)(3) and says GLP-1s including Ozempic, Wegovy and Mounjaro are excluded from coverage for weight loss. (newyork.fhsc.com)
  • The NYRx drug list revised October 22, 2026 allows Wegovy for cardiovascular disease and Zepbound for obstructive sleep apnea only with a BMI of 40 or higher, lifestyle changes, and a limit of two treatment attempts per lifetime. (newyork.fhsc.com)
  • Senate bill S3104 (Sen. Jeremy Cooney) would require coverage of obesity treatment including FDA-approved anti-obesity medication; it was referred to the Senate Health Committee on January 7, 2026. (nysenate.gov)
  • Senate bill S5798 (Sen. Luis Sepulveda) would require Medicaid to cover weight-management drugs for adults with obesity and a weight-related condition; it was referred to the Senate Health Committee on January 7, 2026. (nysenate.gov)
  • Assembly bill A9360 would require New York Medicaid to cover FDA-approved GLP-1s for obesity and metabolic disorders; it was referred to the Assembly Health Committee on January 7, 2026. (nysenate.gov)
  • New York City said in October 2024 it would stop covering GLP-1s for weight loss for city workers in 2025, affecting nearly 1,000 employees; diabetes coverage continues. (businessinsurance.com)
  • 28.5% of New York adults had obesity in 2025 (CDC). (cdc.gov)

Inside NYRx: two exceptions, both at BMI 40

Since April 1, 2023, members of mainstream Medicaid managed care plans, HARPs and HIV special needs plans get their prescriptions through NYRx instead of through their health plan. That means one drug list and one set of rules, whichever plan card is in your wallet. The Essential Plan and Child Health Plus were left out of that move.

The rule itself is blunt. State regulation 18 NYCRR 505.3(g)(3) excludes drugs used for weight loss, and an NYRx notice revised July 16, 2026 says weight loss "is not and never has been a Medicaid-covered indication." Ozempic, Mounjaro and other GLP-1s are covered for type 2 diabetes under clinical criteria.

The NYRx drug list revised October 22, 2026 carries two narrow exceptions. Wegovy can be approved for diagnosed cardiovascular disease and Zepbound for obstructive sleep apnea, each only with a BMI of 40 or higher, proof that the member is making lifestyle changes, and a lifetime cap of two treatment attempts. NYRx also pays for only one GLP-1 at a time and rejects a refill while more than 25% of the last fill is left.

Bills waiting in Albany's committees

Several 2025-2026 bills would change the picture, and none has passed. S3104, sponsored by Senator Jeremy Cooney, would require insurers and Medicaid to cover obesity treatment, including FDA-approved anti-obesity medication, under the same deductibles and copays as other conditions. It was referred to the Senate Health Committee again on January 7, 2026. Its Assembly twin is A4211.

Two narrower bills target Medicaid only. S5798, from Senator Luis Sepulveda, would cover weight-management drugs for adults with obesity and at least one weight-related condition, and A9360, from Assemblymember Angelo Santabarbara, would cover GLP-1s for obesity and metabolic disorders, with room for prior authorization and step therapy. All of these were referred to committee again on January 7, 2026. New York's two-year session ends on December 31, 2026, and bills that have not passed by then must be filed again.

City badge or state badge changes the answer

A city employee and a state employee can work on the same Manhattan block and get opposite answers. In October 2024, Gothamist and Business Insurance reported, New York City told workers it would stop covering Wegovy and Zepbound for weight loss in 2025, a change that hit nearly 1,000 city employees, while keeping diabetes coverage. We found no sign the city has brought weight-loss coverage back.

State workers on the Empire Plan kept it, with prior authorization. If you are a city worker, a Medicaid member, or on an Excellus plan that dropped these drugs, a cash program is usually the fastest start.

GLP-1 in New York: questions

Does the NYSHIP Empire Plan cover Wegovy for weight loss?

Yes, with prior authorization. Wegovy and Zepbound are on the Empire Plan's 2026 drug list. Your clinician submits the request with your medical details. If approval is slow or denied, you can start with a cash program and switch later. The programs on this page serve New York.

Did Excellus stop covering Zepbound and Wegovy?

For certain plans, yes. From January 1, 2026, Excellus removed Wegovy, Zepbound and Saxenda for weight loss from the drug list on some plans. You can still request an exception if your prescriber shows you meet the criteria. Diabetes GLP-1s remain covered. Otherwise, compare the cash options below.

Does New York Medicaid cover Wegovy for weight loss?

No. NYRx, the program that handles Medicaid prescriptions, excludes drugs used for weight loss under state regulation, and GLP-1s are covered for type 2 diabetes instead. Bills in Albany, including S5798 and A9360, would change that, but none has passed. Most Medicaid members who want a GLP-1 for weight loss pay cash through an online program.

Can NY Medicaid cover Wegovy if I have heart disease?

Possibly, under strict terms. The NYRx drug list allows Wegovy for diagnosed cardiovascular disease only with a BMI of 40 or higher and ongoing lifestyle changes, and caps it at two treatment attempts per lifetime. Zepbound has a matching exception for obstructive sleep apnea. Your prescriber has to request prior authorization.

Is New York going to make insurers cover GLP-1s for obesity?

Not yet. S3104 in the Senate and A4211 in the Assembly would require coverage of FDA-approved anti-obesity medication with the same cost sharing as other conditions. Both sat in committee as of November 2026, and the session ends December 31. Until a law passes, coverage depends on your plan's own drug list.

Can I get semaglutide delivered in New York City?

Yes. Online programs that say they serve New York ship to apartments across the five boroughs. Pills skip the cold-chain packaging. You do the medical intake online, so there is no clinic visit to schedule.

What's the cheapest GLP-1 in New York without insurance?

Compounded semaglutide and tirzepatide from online programs that say they serve New York usually cost the least, and several keep one price at every dose. In November 2026 Maximus listed tirzepatide from $99.99 a month on a 12-month plan. Brand-name Wegovy and Zepbound from Maximus cost more. Check the price at your maintenance dose.

Do New York City employees have GLP-1 coverage for weight loss?

Not for weight loss, based on what we found. According to Gothamist and Business Insurance, the city ended weight-loss coverage of Wegovy and Zepbound for its workers in 2025 and kept coverage for diabetes. That is separate from the state's Empire Plan, which still lists both drugs with prior authorization. City workers can compare cash programs like the ones on this page.

See programs for New York All states

Sources: kff.org · cdc.gov · cs.ny.gov